Amanda Chen
@_amandachen
Postdoctoral researcher 👩🏻🔬 | Porteus lab | @Stanford Previously: PhD student | Beavis lab | @PeterMacCC I ❤️ CRISPR, synthetic biology & cell therapies
Excited to share that my PhD work is out in @Nature today! We engineered armoured CAR T cells to express therapeutic payloads only at the tumour site, to improve their safety and efficacy for the treatment of solid cancers. 1/14 nature.com/articles/s4158…
🛡️ Drs. @_AmandaChen, Kah Min Yap, Imran House, Phillip Darcy, and @PaulBeavis4 developed #CRISPR-edited armored CAR T cells that deliver cytokines directly to tumor sites. @Nature article: go.nature.com/3I8Nk8S Discussion: bit.ly/3Gu9UIF
Nature research paper: Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery go.nature.com/4le7GMB
Wow amazing work using NR4A2/RGS16 promoters to trigger IL‑12/IL‑2 only in tumors is brilliant! A big game‑changer in CAR‑T therapy. Huge congrats to @_amandachen and colleagues ! 🎉
Excited to share that my PhD work is out in @Nature today! We engineered armoured CAR T cells to express therapeutic payloads only at the tumour site, to improve their safety and efficacy for the treatment of solid cancers. 1/14 nature.com/articles/s4158…
Pleased to present the latest work from the lab published in @NatureComms in work led by @kevin_sek: nature.com/articles/s4146…
Wow. Endogenous regulatory circuit-generated armoured CAR T cells. Seriously cool. Basic premise is to “armour” CAR T cells by getting them to express pro-inflammatory cytokines only when in tumours. Since T cells in tumours get exhausted and up-regulate PD1, the first approach…
Delighted to share our new approach to enhance CAR T cell function in solid tumours published today @Nature. In this work we identify a new strategy to generate armoured CAR T cells. nature.com/articles/s4158…
Happy to share a new study led by all-star team @_amandachen, @kahmin98, @ImranHouse, Phil Darcy and @paulbeavis4 showing that tumor site-specific delivery of potent cytokines is a safe way to boost CAR T cell treatment against solid cancers! nature.com/articles/s4158…
CAR T cells are engineered to drive tumor-restricted expression of proinflammatory cytokines by repurposing endogenous gene regulatory mechanisms nature.com/articles/s4158… #NBThighlight
In the news today: Peter Mac scientists have developed “Precision Guided Munition” CAR T-cells – smart immune cells that target solid tumours directly. In lab models, they wiped out breast, colon & ovarian tumours with cure rates near 100%! More: petermac.org/about-us/news-…
Dedicating my first post on X to share some exciting news — our work is out today in @Nature! 🎉 Co-first authored with the amazing lab buddy @_amandachen, and guided by our incredible supervisors @paulbeavis4, Phil & @ImranHouse. nature.com/articles/s4158…
Fresh off the press! ♨️ Scientists, including @_amandachen & @paulbeavis4, developed a #CRISPR knock-in strategy that leverages the regulatory mechanisms of endogenous genes to drive transgene expression in a tumor-localized manner. @nature | go.nature.com/3I8Nk8S
NR4A2 & RGS16 promoters support delivery of cytokines (e.g. IL-12) directly to the tumor site, leading to enhanced antitumor efficacy and long-term survival of mice in both syngeneic and xenogeneic models @Nature @paulbeavis4 @_amandachen @emsderrick nature.com/articles/s4158…
Delighted to share our new approach to enhance CAR T cell function in solid tumours published today @Nature. In this work we identify a new strategy to generate armoured CAR T cells. nature.com/articles/s4158…